DeğerQ4, 24Q1, 25Q2, 25TTMSelling/general/admin expenses265.13 M259.19 M278.4 M1.05 BResearch & development86.44 M87.32 M90.97 M348.68 MFaaliyet karı454.54 M446.54 M491.66 M1.82 BFaaliyet Dışı Gelir, Toplam3.51 M256 K4.49 M-317 KFaiz gideri (aktifleştirilmiş faiz düşüldükten sonra)————Faaliyet Dışı Gelir (Faiz Giderleri Hariç)4.49 M4.09 M9.77 M13.84 MOlağandışı gelir/gider-979 K-3.84 M-5.28 M-14.15 MVergi öncesi kar458.05 M446.79 M496.15 M1.82 BKazançlardaki özsermayeler1.27 M1.49 M1.51 M4.61 MVergiler78.35 M98.26 M103.56 M332.81 MKontrol gücü olmayan/azınlık payları————Vergi sonrası diğer gelirler/giderler————Durdurulan faaliyetler öncesi net kar379.7 M348.54 M392.59 M1.49 BDurdurulan faaliyetler————Net kar379.7 M348.54 M392.59 M1.49 BSeyreltme ayarlaması————İmtiyazlı temettüler————Adi hisse senedi sahiplerine düşen seyreltilmiş net kar379.7 M348.54 M392.59 M1.49 BTemel hisse başına kazanç (Temel EPS)2.592.382.6910.15Seyreltilmiş hisse başına kazanç (Seyreltilmiş EPS)2.582.372.6810.11Dolaşımdaki ortalama adi hisse sayısı146.72 M146.18 M145.84 M585.46 MSeyreltilmiş hisse sayısı147.34 M146.9 M146.37 M587.83 MFAVÖK518.17 M494.24 M541.54 M2.02 BFVÖK454.54 M446.54 M491.66 M1.82 BGelir maliyeti527.93 M514.76 M544.08 M2.11 BSatılan malların diğer maliyeti518.56 M506.94 M536.28 M2.08 BDepreciation & amortization (cash flow)63.63 M47.7 M49.88 M204.89 M
ResMed Inc
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.